Overview
- IndustryElectromedical & Electrotherapeutic Apparatus1
- HeadquartersOld Greenwich, Connecticut1
- Incorporated inDE2
- Business address53 Forest Avenue, Suite 101, Old Greenwich, Ct 068702
- Filer categoryNon-accelerated filer, Smaller reporting company2
See how the biggest companies compare on our leaderboards
Star Equity Holdings, Inc. (“Star Equity,” the “Company,” “we,” “our”) is a diversified multi-industry holding company with two divisions. Our Building Solutions division, formerly called our “Construction” division, is our largest division and operates in the construction industry, a key sector of the economy. In addition, we have an Investments division. On May 4, 2023, we completed the sale of our former healthcare division, Digirad Health, Inc. (“Digirad Health”). Until the sale of Digirad Health, we were organized into three divisions.4 From its latest annual report
Financials
From the company’s reports to the SEC. Every number links to the filing it came from.
Key numbers, fiscal 2024
Where the money goes
Where each dollar of revenue went, fiscal 2024
- Cost of revenue71¢$42.3M
- Selling, general and admin29¢$17.0M
- Income tax0¢$263.0K
Out of $53.4M in revenue.5 The company lost money this year.
Financial statements
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Revenue | $93.4M6 | $72.9M7 | $78.2M8 | $106.6M9 | $57.1M10 | $45.8M5 | $53.4M5 |
| Cost of revenue | $85.9M11 | $55.8M7 | $64.2M8 | $91.3M9 | $44.8M10 | $33.9M5 | $42.3M5 |
| Gross profit | $18.3M11 | $17.2M7 | $14.0M8 | $15.2M9 | $12.4M10 | $11.9M5 | $11.1M5 |
| Research and development | |||||||
| Selling, general and admin | $14.2M10 | $14.5M5 | $17.0M5 | ||||
| Operating expenses | $26.8M9 | $15.9M10 | $16.3M5 | $19.5M5 | |||
| Operating income | -$4.5M11 | -$1.9M7 | -$7.2M8 | -$11.6M9 | -$3.5M10 | -$4.3M5 | -$8.4M5 |
| Interest | $905.0K9 | $975.0K9 | |||||
| Income before tax | -$8.9M9 | -$5.4M10 | -$2.5M5 | -$10.2M5 | |||
| Income tax | -$1.6M11 | -$199.0K7 | $129.0K8 | $60.0K9 | $383.0K10 | -$614.0K5 | $263.0K5 |
| Net income | $736.0K11 | -$4.6M7 | -$6.5M8 | -$3.0M9 | -$5.3M10 | $25.1M5 | -$10.4M5 |
| Earnings per share | -$1.768 | -$0.599 | -$0.3610 | $8.035 | -$3.325 | ||
| Earnings per share (diluted) | -$1.768 | -$0.599 | -$0.3510 | $8.035 | -$3.325 | ||
| Shares (weighted, basic) | 5.1M shares9 | 14.8M shares10 | 3.1M shares5 | 3.1M shares5 | |||
| Shares (weighted, diluted) | 5.1M shares9 | 14.8M shares10 | 3.1M shares5 | 3.1M shares5 |
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash | $1.5M11 | $1.7M7 | $3.2M8 | $4.5M9 | $4.4M10 | $18.3M5 | $4.0M5 |
| Receivables | $15.8M9 | $8.0M10 | $6.0M5 | $8.0M5 | |||
| Inventory | $8.5M9 | $4.7M10 | $3.4M5 | $5.4M5 | |||
| Current assets | $21.2M11 | $29.5M7 | $48.9M8 | $31.9M9 | $39.3M10 | $34.8M5 | $24.4M5 |
| Property, plant and equipment | $8.9M9 | $5.7M10 | $7.8M5 | $10.2M5 | |||
| Goodwill | $6.0M9 | $4.4M10 | $4.4M5 | $8.5M5 | |||
| Intangible assets | $15.1M9 | $13.4M10 | $12.5M5 | $18.9M5 | |||
| Total assets | $50.6M11 | $90.6M7 | $89.5M8 | $68.1M9 | $73.3M10 | $75.5M5 | $83.0M5 |
| Accounts payable | $4.3M9 | $1.4M10 | $1.6M5 | $2.6M5 | |||
| Short-term debt | $12.9M8 | $3.4M10 | $2.0M5 | $3.9M5 | |||
| Current liabilities | $13.2M11 | $44.5M7 | $43.0M8 | $27.8M9 | $27.5M10 | $8.7M5 | $12.5M5 |
| Long-term debt | $9.5M11 | $740.0K7 | $3.7M8 | $08 | $05 | $7.4M5 | |
| Total liabilities | $24.8M11 | $49.9M7 | $49.5M8 | $32.3M9 | $31.5M10 | $10.2M5 | $28.7M5 |
| Retained earnings | -$128.0M9 | -$133.2M10 | -$108.1M5 | -$118.5M5 | |||
| Shareholders’ equity | $25.8M7 | $21.1M8 | $18.4M9 | $16.8M10 | $41.8M5 | $65.3M5 | $54.3M5 |
| Shares outstanding | 2.0M shares11 | 2.1M shares7 | 4.8M shares8 | 5.8M shares9 | 15.2M shares10 | 3.2M shares5 | 3.2M shares5 |
Cash flow is reported year to date, not quarter by quarter, so there are no separate quarterly figures.
| Fiscal year | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|
| Cash from operations | $5.1M11 | $400.0K7 | -$5.0M8 | -$6.5M9 | -$3.9M10 | $2.7M5 | -$5.2M5 |
| Depreciation and amortization | $3.5M9 | $2.3M10 | $2.3M5 | $3.6M5 | |||
| Stock-based compensation | $527.0K9 | $438.0K10 | $340.0K5 | $240.0K5 | |||
| Capital spending | $2.2M11 | $1.5M7 | $1.5M8 | $788.0K9 | $1.2M10 | $698.0K5 | $2.9M5 |
| Free cash flow | $2.9M | -$1.1M | -$6.4M | -$7.2M | -$5.0M | $2.0M | -$8.0M |
| Cash from investing | $17.8M9 | -$5.1M10 | $16.2M5 | -$12.0M5 | |||
| Dividends paid | $3.3M11 | $011 | |||||
| Share buybacks | $74.0K11 | $24.0K7 | $10.0K8 | $18.0K8 | $05 | $279.0K5 | |
| Cash from financing | -$10.0M9 | $8.9M10 | -$3.1M5 | $3.9M5 | |||
| Dividend per share | $1.6511 | -$0.297 | -$0.527 |
Corporate structure
STAR OPERATING COMPANIES, INC. sits at the top of its group. 2 entities, 1 country on record. Switch between the flow chart and the network, and select any entity to see its details.
Major holders of STAR OPERATING COMPANIES, INC.
- Jeffrey E. Eberwein Filed SCHEDULE 13D/A on STAR OPERATING COMPANIES, INC., latest Aug 22, 2025 (8 filings since Dec 20, 2021)
- A. Gile & Co. LLC Filed SCHEDULE 13G/A on STAR OPERATING COMPANIES, INC., latest Dec 26, 2024 (2 filings since Jul 19, 2024)
- STAR OPERATING COMPANIES, INC. Old Greenwich, Connecticut
- State of Incorporation Subsidiary · Delaware, United States
Built from subsidiaries listed in Exhibit 21 of annual reports filed with the SEC; major holders from Schedules 13D and 13G. Each entity in the chart links to its source.
What it owns
What STAR OPERATING COMPANIES, INC. reports owning in its annual reports to the SEC: buildings, land and equipment, real estate and locations, investments, intangible assets and inventory, at the end of its latest fiscal year and a year before.
Property and equipment
| Item | Latest | A year before | Change |
|---|---|---|---|
| Property and equipment, before depreciation | $12.9M5 Dec 31, 2024 | $10.0M5 Dec 31, 2023 | +29.2% |
| Accumulated depreciation | $2.7M5 Dec 31, 2024 | $2.2M5 Dec 31, 2023 | +25.1% |
| Property and equipment, net | $10.2M5 Dec 31, 2024 | $7.8M5 Dec 31, 2023 | +30.4% |
| Operating-lease assets (leased space) | $8.3M5 Dec 31, 2024 | $1.5M5 Dec 31, 2023 | +463.9% |
Investments
| Item | Latest | A year before | Change |
|---|---|---|---|
| Cash and cash equivalents | $4.0M5 Dec 31, 2024 | $18.3M5 Dec 31, 2023 | −78.2% |
| Marketable securities, current | $3.4M5 Dec 31, 2024 | $4.8M5 Dec 31, 2023 | −30.4% |
| Equity securities at fair value | $3.4M5 Dec 31, 2024 | $4.8M5 Dec 31, 2023 | −30.4% |
| Long-term investments | $2.1M5 Dec 31, 2024 | $6.0M5 Dec 31, 2023 | −64.3% |
Intangibles and goodwill
| Item | Latest | A year before | Change |
|---|---|---|---|
| Goodwill | $8.5M5 Dec 31, 2024 | $4.4M5 Dec 31, 2023 | +90.5% |
| Intangible assets, net (excluding goodwill) | $18.9M5 Dec 31, 2024 | $12.5M5 Dec 31, 2023 | +51.2% |
| Finite-lived intangibles, gross | $28.8M5 Dec 31, 2024 | $19.9M5 Dec 31, 2023 | +44.6% |
| Accumulated amortization | $9.9M5 Dec 31, 2024 | $7.4M5 Dec 31, 2023 | +33.5% |
| Finite-lived intangibles, net | $18.9M5 Dec 31, 2024 | $12.5M5 Dec 31, 2023 | +51.2% |
Inventory
| Item | Latest | A year before | Change |
|---|---|---|---|
| Inventory, total | $5.4M5 Dec 31, 2024 | $3.4M5 Dec 31, 2023 | +57.8% |
| Raw materials | $2.6M5 Dec 31, 2024 | $1.4M5 Dec 31, 2023 | +89.7% |
| Work in process | $735.0K5 Dec 31, 2024 | $410.0K5 Dec 31, 2023 | +79.3% |
| Finished goods | $2.0M5 Dec 31, 2024 | $1.6M5 Dec 31, 2023 | +24.9% |
Properties, in its own words
Our principal executive offices are in Old Greenwich, Connecticut, where we lease 2,006 square feet of office space.
In April 2019, our Investments division (through Star Real Estate, “SRE”) acquired three manufacturing facilities in Maine, which it then leased back to KBS in our Building Solutions segment. These included KBS’s 84,800 square foot main production facility in South Paris, Maine and a 92,200 square foot manufacturing facility in Oxford, Maine. We sold our Waterford, Maine production facility in June 2023. In July 2024 we sold and immediately leased back our property at South Paris, Maine.
The rest of Item 2
We utilize four additional facilities in our Building Solutions businesses, related specifically to EBGL. In October 2021, we extended two existing leases, a 10,800 square foot office/sales/showroom space in Oakdale, Minnesota and a 34,200 square foot production facility in Prescott, Wisconsin. In addition, we entered into a lease in October 2021 for 22,800 square feet of lumberyard/warehouse space in Hudson, Wisconsin. With the BLL acquisition in late 2023, we acquired a fourth facility, a 22,300 square foot lumberyard/warehouse/showroom space in Big Lake, Minnesota. This property was sold and immediately leased back in July 2024. With the TT acquisition in June 2024, we acquired a 89,000 square foot manufacturing facility in Colfax, Wisconsin. In December 2024, we acquired the Prescott, Wisconsin production facility we were leasing and immediately sold it and entered into a sale leaseback transaction. See Note 10. Leases for further detail on our leases.
We believe that we have adequate space for our anticipated needs and that suitable additional space will be available at commercially reasonable prices as needed.
Item 2 of the 10-K filed Mar 21, 2025.4
Leadership
Who has led STAR OPERATING COMPANIES, INC., and when. Pick a name to see everywhere that person has worked.
Chief executive
President
Chief financial officer
- Chief executive officerRaymond William Vogel Jan 5, 2016 to Feb 3, 201714
- Chief executive officerMatthew G. Molchan Sep 5, 2013 to Mar 3, 202215
- Chief executive officerTodd P. Clyde Nov 13, 2008 to Jul 2, 201316
- Chief executive officerMark Casner Jan 11, 2006 to Jul 29, 200817
- ChairJeffrey E. Eberwein Apr 2, 2021 to now18
- PresidentThatcher Butcher Aug 17, 2023 to now19
- PresidentMartin B. Shirley Mar 8, 2016 to May 8, 202320
- PresidentVirgil Lott Jun 6, 2013 to May 25, 201821
- PresidentMatthew G. Molchan Jan 11, 2012 to May 29, 202022
- PresidentTodd P. Clyde Nov 13, 2008 to Apr 5, 201316
- PresidentPeter Sullivan May 3, 2006 to May 3, 200623
- PresidentMark Casner Dec 26, 2006 to Jul 29, 200824
- PresidentMichael J. Keenan Dec 26, 2006 to May 13, 200825
- Chief financial officerMatthew G. Molchan Sep 7, 2018 to Sep 7, 201826
- Chief financial officerJeffry R. Keyes Sep 7, 2012 to Mar 1, 201827
- Chief financial officerRichard B. Slansky Mar 9, 2009 to Apr 12, 201228
- Chief financial officerTodd P. Clyde May 3, 2006 to Oct 11, 201229
Board members and other officers (35)
- General Manager,Mobile ImagingMichael Debeauvernet Feb 5, 2018 to Feb 5, 201930
- SVP, Sales & MarketingMartin B. Shirley Apr 11, 2014 to Feb 3, 201631
- SVP, Commercial Ops & Bus DevSarah L. Hanssen Sep 13, 2012 to Apr 24, 201332
- SVP of Product SalesArmando Jackson Jul 12, 2011 to Aug 3, 201133
- Senior VP, OperationsVirgil Lott Oct 30, 2009 to Apr 5, 201334
- Pres.,Digirad Imaging ProductsPeter Sullivan Jan 11, 2006 to Jan 11, 200635
- Sr. VP of Sales and MarketingRandy Weatherhead Jan 11, 2006 to Apr 27, 201136
- Pres,Digirad Imaging SolutionsMichael J. Keenan Apr 4, 2006 to Apr 4, 200637
- VP Corp Radiation SafetyPaul J. Early May 3, 2006 to May 21, 200738
- VP of TechnologyRichard L. Conwell May 3, 2006 to Dec 26, 200639
- VP, Clinical OperationsFreire Lima May 10, 2006 to Jul 14, 200640
- Board memberJennifer Palmer Jul 10, 2024 to now41
- Board memberLouis A. Parks Jul 10, 2024 to now42
- Board memberTodd Michael Fruhbeis Jul 10, 2024 to now43
- Board memberMitchell I. Quain Jan 22, 2019 to now44
- Board memberDimitrios Angelis Aug 11, 2015 to May 19, 202045
- Board memberMichael A. Cunnion Jun 26, 2014 to now46
- Board memberMatthew G. Molchan Sep 5, 2013 to Aug 25, 202115
- Board memberCharles M. Gillman Apr 25, 2012 to Aug 8, 201847
- Board memberJames B. Hawkins Apr 25, 2012 to Aug 8, 201448
- Board memberJeffrey E. Eberwein Apr 25, 2012 to Nov 20, 202049
- Board memberJohn M. Climaco Jun 5, 2012 to Aug 19, 201950
- Board memberLloyd H. Malchow May 19, 2009 to May 19, 200951
- Board memberSteven C. Mendell May 21, 2009 to May 12, 201152
- Board memberJohn W. Sayward Apr 25, 2008 to now53
- Board memberTodd P. Clyde Nov 13, 2008 to Apr 5, 201316
- Board memberGerhard F. Burbach May 8, 2007 to May 22, 201254
- Board memberMark Casner Jan 11, 2006 to Jul 29, 200817
- Board memberDouglas Reed Md. Feb 28, 2006 to Apr 24, 200855
- Board memberTimothy J. Wollaeger Mar 1, 2006 to May 8, 200756
- Board memberR. King Nelson Mar 9, 2006 to May 12, 201157
- Board memberKenneth E. Olson Mar 13, 2006 to May 12, 201158
- Board memberRaymond Dittamore V. May 2, 2006 to May 8, 200759
- General counselHannah M. Bible Apr 8, 2022 to now60
- General counselVera P. Pardee May 3, 2006 to Dec 26, 200661
Subsidiaries and ownership
Subsidiaries (Exhibit 21)
- State of Incorporation Delaware3
The subsidiaries the company lists in Exhibit 21 of its annual report, as filed.
Former names
Timeline
- Aug 22, 20258-K Completed an acquisition or sale; Listing notice or transfer; Change to shareholders' rights62
- Aug 21, 20258-K Shareholder vote63
- Aug 15, 20258-K Other events64
- Aug 13, 20258-K Results of operations65
- Aug 8, 20258-K Other events66
- Jul 28, 20258-K Listing notice or transfer67
- Jul 22, 20258-K Other events68
- May 22, 20258-K Entered a material agreement; Regulation FD disclosure69
- May 20, 20258-K Other events70
- May 14, 20258-K Results of operations71
- May 13, 20258-K Financial statements and exhibits72
- Mar 20, 20258-K Results of operations73
- Jan 5, 2016New chief executive Raymond William Vogel becomes CEO14
- Sep 5, 2013New chief executive Matthew G. Molchan becomes CEO15
- Nov 13, 2008New chief executive Todd P. Clyde becomes CEO16
- Jan 11, 2006New chief executive Mark Casner becomes CEO17
Calendar
When it reported results
- Aug 13, 2025Reported quarterly or annual results65
- May 14, 2025Reported quarterly or annual results71
- Mar 20, 2025Reported quarterly or annual results73
- Mar 5, 2025Reported quarterly or annual results74
- Mar 4, 2025Reported quarterly or annual results75
- Nov 19, 2024Reported quarterly or annual results76
- Aug 13, 2024Reported quarterly or annual results77
- May 20, 2024Reported quarterly or annual results78
Upcoming dates from Nasdaq's calendar; past results from the company's 8-K filings (Item 2.02). The full markets calendar
Filings
388 filings to the SEC since October 2021: 5 annual reports, 12 quarterly reports, 103 major events, 204 insider forms, 15 large holders, 49 other. The latest 20:
- Sep 10, 2025EFFECT EDGAR
- Sep 10, 2025EFFECT EDGAR
- Sep 10, 2025EFFECT EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025POS AM EDGAR
- Sep 5, 2025POS AM EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025POS AM EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 5, 2025S-8 POS EDGAR
- Sep 3, 202515-12G EDGAR
- Aug 22, 2025SCHEDULE 13D/A EDGAR
- Aug 22, 202525-NSE EDGAR
- Aug 22, 20258-K EDGAR
- Aug 22, 20254 EDGAR
- Aug 22, 20254 EDGAR
- Aug 22, 20254 EDGAR
The 388 filings since October 2021 can be filtered by form type and year here when JavaScript is on.
Every filing from the last five years, summarized. The full record is on SEC EDGAR.
Insider trades
194 open-market trades by officers, directors and large owners since October 2021: 140 buys and 54 sales. Grants, option exercises and gifts are left out.
| Date | Who | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Aug 20, 2024 | Coleman Richard Kenneth Jr.Chief Executive Officer | Buy | 500 | $4.15 | $2.1K | Form 4 |
| Aug 19, 2024 | Coleman Richard Kenneth Jr.Chief Executive Officer | Buy | 1,000 | $4.25 | $4.2K | Form 4 |
| Aug 16, 2024 | Coleman Richard Kenneth Jr.Chief Executive Officer | Buy | 1,500 | $6.18 | $9.3K | Form 4 |
| Dec 14, 2023 | Butcher ThatcherPresident - KBS | Buy | 3,000 | $1.04 | $3.1K | Form 4 |
| Nov 30, 2023 | Coleman Richard Kenneth Jr.Chief Executive Officer | Buy | 4,000 | $5.28 | $21.1K | Form 4 |
| Nov 22, 2023 | Schumacher Ronald A.Exec Chairman - EdgeBuilder | Buy | 2,000 | $1.03 | $2.1K | Form 4 |
| Nov 22, 2023 | Coleman Richard Kenneth Jr.Chief Executive Officer | Buy | 5,000 | $1.04 | $5.2K | Form 4 |
| Sep 15, 2023 | Eberwein Jeffrey E.Executive Chairman | Sale | 298 | $9.39 | $2.8K | Form 4 |
| Sep 14, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 23,669 | $1.11 | $26.3K | Form 4 |
| Sep 13, 2023 | Eberwein Jeffrey E.Executive Chairman | Sale | 1,902 | $9.39 | $17.9K | Form 4 |
| Sep 11, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 46,280 | $1.11 | $51.4K | Form 4 |
| Sep 11, 2023 | Eberwein Jeffrey E.Executive Chairman | Sale | 1,879 | $9.39 | $17.6K | Form 4 |
| Sep 7, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 39,855 | $1.07 | $42.6K | Form 4 |
| Sep 7, 2023 | Eberwein Jeffrey E.Executive Chairman | Sale | 4,650 | $9.39 | $43.7K | Form 4 |
| Sep 6, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 1,716 | $1.05 | $1.8K | Form 4 |
| Sep 5, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 22,316 | $1.06 | $23.7K | Form 4 |
| Sep 1, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 39,821 | $1.06 | $42.2K | Form 4 |
| Aug 29, 2023 | Eberwein Jeffrey E.Executive Chairman | Buy | 28,681 | $1.01 | $29.0K | Form 4 |
| Aug 29, 2023 | Eberwein Jeffrey E.Executive Chairman | Sale | 5,356 | $9.40 | $50.3K | Form 4 |
| Aug 25, 2023 | QUAIN MITCHELL IDirector | Buy | 40,000 | $1.00 | $40.0K | Form 4 |
All 194 trades can be filtered by person here when JavaScript is on.
From Forms 4 filed with the SEC.
Major holders
Investors who own more than 5% of the shares must tell the SEC: a 13D if they may seek to influence the company, a 13G if they hold passively.
- Jeffrey E. EberweinSCHEDULE 13D/A, 8 filings Dec 20, 2021 to Aug 22, 202579
- A. Gile & Co. LLCSCHEDULE 13G/A, 2 filings Jul 19, 2024 to Dec 26, 202480
SEC filer profile
How STAR OPERATING COMPANIES, INC. is registered with the Securities and Exchange Commission, from its EDGAR record and the cover page of its latest annual report.
- Name on EDGARSTAR OPERATING COMPANIES, INC.1
- CIK0000707388
- Employer ID (EIN)33-01457234
- Filer statusNon-accelerated filer not an emerging growth company; a smaller reporting company; not a shell company4
- Incorporated inDelaware4
- Fiscal year endsDecember 311
- Industry code (SIC)3845 Electromedical & Electrotherapeutic Apparatus1
- SEC reviewing officeOffice of Industrial Applications and Services, Division of Corporation Finance1
- Business address53 Forest Avenue, Suite 101, Old Greenwich, CT 068701
- Mailing address53 Forest Ave, Suite 101, Old Greenwich, CT 068701
- Phone203-489-95011
- Shares outstanding3,234,978 as of Aug 8, 202513
- Public float$5.1M as of Jun 30, 20244
- AuditorWolf & Company, P.C., Boston, MA PCAOB ID 392; no auditor attestation of internal control over financial reporting4
- On EDGAR sinceAug 24, 20011
- Filings1,620 in all: 4 (816), 8-K (313), 10-Q (64), 3 (62), SC 13G/A (53), SC 13D/A (28), 10-K (21), SC 13G (20)1
All 57 form types
DEF 14A (19), CORRESP (17), 4/A (15), 8-K/A (14), DEFA14A (11), DFAN14A (11), S-1/A (11), EFFECT (10), PRE 14A (10), SD (10), UPLOAD (10), S-8 POS (9), ARS (7), S-8 (7), SC 13D (7), S-1 (6), 10-K/A (5), 425 (5), FWP (5), 8-A12B (4), CT ORDER (4), 3/A (3), 424B3 (3), DEFC14A (3), NT 10-Q (3), POS AM (3), PREC14A (3), S-3 (3), 424B4 (2), 8-A12G (2), PRRN14A (2), RW (2), 10-Q/A (1), 15-12G (1), 25-NSE (1), 424B1 (1), 5 (1), CERT (1), D (1), DEFM14A (1), DEFR14A (1), S-4 (1), S-4/A (1), SC TO-C (1), SC TO-I (1), SC TO-I/A (1), SCHEDULE 13D/A (1), SCHEDULE 13G (1), SCHEDULE 13G/A (1)
- Latest filingsAnnual report (10-K) Mar 21, 2025
Quarterly report (10-Q) Aug 13, 2025
Proxy statement (DEF 14A) Sep 6, 2024
Latest 8-K (8-K) Aug 22, 2025
Securities registered for trading
| Class | Symbol | Exchange |
|---|---|---|
| Common Stock, par value $0.0001 per share | STRR | NASDAQ Global Market |
| Series A Cumulative Perpetual Preferred Stock, par value $0.0001 per share | STRRP | NASDAQ Global Market |
| Series C Participating Preferred Stock, par value $0.0001 per share Purchase Rights |
From the cover page of the 10-K filed Mar 21, 2025 (Section 12(b) of the Exchange Act).4
Risk factors and legal proceedings
The risks STAR OPERATING COMPANIES, INC. names in Item 1A of its 10-K filed Mar 21, 2025: 31 risks under these headings, as written.4
- Risks Related to Our Business and Industry
- We have a history of annual net losses attributable to common stockholders which may continue and which may negatively impact our ability to achieve our growth initiatives.
- We rely on information technology in our operations, and any material failure, inadequacy, interruption, or security failure of that technology could materially harm our business.
- We may not be able to achieve the anticipated synergies and benefits from business acquisitions.
- We face risks related to health pandemics, wars, inflation, and other potential causes of global instability which could significantly disrupt our operations and impact our financial results.
- We are subject to particular risks associated with real estate ownership, which could result in unanticipated losses or expenses.
- Operating results may be adversely affected by changes in the costs and availability of supplies and materials.
- Trade tariffs or other factors affecting the commodities and materials we use in our business could have a material and adverse impact on our results of operations, financial condition and cash flows.
- Our quarterly and annual financial results are difficult to predict and are likely to fluctuate from period to period.
- We spend considerable time and money complying with federal and state laws, regulations, and other rules which may fluctuate, and if we are unable to fully comply with such laws, regulations, and other rules, we could face substantial penalties.
- Our long-term results depend upon our ability to improve existing products and services and develop, introduce, and market new products and services successfully.
- We may make financial investments in other businesses that may lose value.
The other 20 risks
- Our goodwill and other long-lived assets are subject to potential impairment that could negatively impact our earnings.
- If KBS is unable to maintain or establish its relationships with independent dealers and contractors who sell its homes, KBS revenue could decline.
- Due to the nature of our business, many of our expenses are fixed costs and if there are decreases in demand for products, it may adversely affect operating results.
- Due to the nature of the work we and our subsidiaries perform, we may be subject to significant liability claims and disputes.
- Persistent inflation could negatively impact our revenues, profitability and borrowing costs. In addition, if our costs increase and we are not able to correspondingly adjust our commercial relationships to account for this increase, our net income would be adversely affected, and the adverse impact may be material.
- Changing rules, public disclosure regulations and stakeholder expectations on environmental, social and corporate governance (“ESG”) related matters expose us to potential liabilities, increased costs, reputational harm and other adverse effects on our business.
- Risks Related to Indebtedness
- Any indebtedness incurred by the Company could restrict our operations and make us more vulnerable to adverse economic conditions.
- If we are unable to generate or borrow sufficient cash to make payments on our indebtedness, our financial condition would be materially harmed, our business could fail, and stockholders may lose all of their investment.
- Risks Related to our Common Stock and our Company Preferred Stock
- The market price of our common stock may be volatile, and the value of your investment could decline significantly.
- Our common stock has a low trading volume and shares available under our equity compensation plans could affect the trading price of our common stock.
- If we cannot continue to satisfy the Nasdaq Global Market continued listing standards and other Nasdaq rules, our common stock could be delisted, which would harm our business, the trading price of our common stock, our ability to raise additional capital and the liquidity of the market for our common stock.
- A possible “short squeeze” due to a sudden increase in demand of our common stock that largely exceeds supply may lead to price volatility in our common stock.
- Payment of dividends on our common stock is prohibited unless we have declared and paid (or set apart for payment) full accumulated dividends on the Series A Preferred Stock, which also has a significant liquidation value.
- If we fail to pay dividends on our Series A Preferred Stock for six or more consecutive quarters, holders of our Series A Preferred Stock will be entitled to elect two additional directors to our board of directors.
- As a smaller reporting company, we are subject to scaled disclosure requirements that may make it more challenging for investors to analyze and compare our results of operations and financial prospects.
- If securities or industry analysts do not publish research or reports about our business, or if they issue an adverse or misleading opinion regarding our stock, the price and trading volume of our securities could decline.
- The protective amendment contained in our Restated Certificate of Incorporation, which is intended to help preserve the value of certain income tax assets, primarily tax net operating loss carryforwards, may have unintended negative effects.
- Our stockholder rights plan, or “poison pill,” includes terms and conditions which could discourage a takeover or other transaction that stockholders may consider favorable.
- Anti-takeover provisions in our organizational documents and Delaware law may prevent or delay removal of current management or a change in control.
- We expect to be limited in our ability to utilize net operating loss carryforwards to reduce our future tax liability as a result of our January 2022 public offering.
Legal proceedings
See Note 9. Commitments and Contingencies, within the notes to our accompanying consolidated financial statements for a summary of any legal proceedings.
The opening of Item 3, Legal Proceedings.4
Sources
The numbers on this page point here. Each one links to the record it came from.
- 1
- 2
- 3
- 4
- 5
- 6
- 7
- 8
- 9
- 10
- 11
- 12
- 13
- 14
- 15
- 16
- 17SEC EDGARMark Casner, Chief executive officer
- 18SEC EDGARJeffrey E. Eberwein, Chair
- 19SEC EDGARThatcher Butcher, President
- 20SEC EDGARMartin B. Shirley, President
- 21SEC EDGARVirgil Lott, President
- 22SEC EDGARMatthew G. Molchan, President
- 23SEC EDGARPeter Sullivan, President
- 24SEC EDGARMark Casner, President
- 25SEC EDGARMichael J. Keenan, President
- 26
- 27
- 28
- 29
- 30
- 31
- 32
- 33
- 34SEC EDGARVirgil Lott, Senior VP, Operations
- 35
- 36
- 37
- 38
- 39SEC EDGARRichard L. Conwell, VP of Technology
- 40SEC EDGARFreire Lima, VP, Clinical Operations
- 41SEC EDGARJennifer Palmer, Board member
- 42SEC EDGARLouis A. Parks, Board member
- 43SEC EDGARTodd Michael Fruhbeis, Board member
- 44SEC EDGARMitchell I. Quain, Board member
- 45SEC EDGARDimitrios Angelis, Board member
- 46SEC EDGARMichael A. Cunnion, Board member
- 47SEC EDGARCharles M. Gillman, Board member
- 48SEC EDGARJames B. Hawkins, Board member
- 49SEC EDGARJeffrey E. Eberwein, Board member
- 50SEC EDGARJohn M. Climaco, Board member
- 51SEC EDGARLloyd H. Malchow, Board member
- 52SEC EDGARSteven C. Mendell, Board member
- 53SEC EDGARJohn W. Sayward, Board member
- 54SEC EDGARGerhard F. Burbach, Board member
- 55SEC EDGARDouglas Reed Md., Board member
- 56SEC EDGARTimothy J. Wollaeger, Board member
- 57SEC EDGARR. King Nelson, Board member
- 58SEC EDGARKenneth E. Olson, Board member
- 59SEC EDGARRaymond Dittamore V., Board member
- 60SEC EDGARHannah M. Bible, General counsel
- 61SEC EDGARVera P. Pardee, General counsel
- 62
- 63SEC EDGARShareholder vote
- 64SEC EDGAROther events
- 65SEC EDGARResults of operations
- 66SEC EDGAROther events
- 67SEC EDGARListing notice or transfer
- 68SEC EDGAROther events
- 69
- 70SEC EDGAROther events
- 71SEC EDGARResults of operations
- 72SEC EDGARFinancial statements and exhibits
- 73SEC EDGARResults of operations
- 74
- 75
- 76
- 77
- 78
- 79
- 80